Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Determinants of self- and carer-rated quality of life and caregiver burden in Alzheimer disease.

Schumann C, Alexopoulos P, Perneczky R.

Int J Geriatr Psychiatry. 2019 Apr 26. doi: 10.1002/gps.5126. [Epub ahead of print]

PMID:
31025764
2.

Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.

Alexopoulos P, Thierjung N, Economou P, Werle L, Buhl F, Kagerbauer S, Papanastasiou AD, Grimmer T, Gourzis P, Berthele A, Hemmer B, Kübler H, Martin J, Politis A, Perneczky R.

J Alzheimers Dis. 2019;69(1):83-90. doi: 10.3233/JAD-181088.

PMID:
30909232
3.

CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.

Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky R; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Feb;74:182-190. doi: 10.1016/j.neurobiolaging.2018.10.022. Epub 2018 Oct 25.

PMID:
30458365
4.

No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients.

Baradaran-Heravi Y, Dillen L, Nguyen HP, Van Mossevelde S, Baets J, De Jonghe P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenberghe R, Van Damme P, Cras P, Salmon E, Synofzik M, Heutink P, Wilke C, Simon-Sanchez J, Rojas-Garcia R, Turon-Sans J, Lleó A, Illán-Gala I, Clarimón J, Borroni B, Padovani A, Pastor P, Diez-Fairen M, Aguilar M, Gelpi E, Sanchez-Valle R, Borrego-Ecija S, Matej R, Parobkova E, Nacmias B, Sorbi S, Bagnoli S, de Mendonça A, Ferreira C, Fraidakis MJ, Diehl-Schmid J, Alexopoulos P, Almeida MR, Santana I, Van Broeckhoven C, van der Zee J; BELNEU Consortium; EU EOD Consortium.

Neurobiol Aging. 2018 Sep;69:293.e9-293.e11. doi: 10.1016/j.neurobiolaging.2018.05.005. Epub 2018 May 23.

5.

Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease.

Alexopoulos P, Thierjung N, Grimmer T, Ortner M, Economou P, Assimakopoulos K, Gourzis P, Politis A, Perneczky R; The Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2018;45(3-4):152-161. doi: 10.1159/000488481. Epub 2018 May 22.

6.

Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and 18F-FDG PET.

Riederer I, Bohn KP, Preibisch C, Wiedemann E, Zimmer C, Alexopoulos P, Förster S.

Radiology. 2018 Jul;288(1):198-206. doi: 10.1148/radiol.2018170575. Epub 2018 May 15.

PMID:
29762090
7.

Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer's disease.

Göttler J, Preibisch C, Riederer I, Pasquini L, Alexopoulos P, Bohn KP, Yakushev I, Beller E, Kaczmarz S, Zimmer C, Grimmer T, Drzezga A, Sorg C.

J Cereb Blood Flow Metab. 2018 Feb 12:271678X18759182. doi: 10.1177/0271678X18759182. [Epub ahead of print]

PMID:
29431005
8.

Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.

Alexopoulos P, Roesler J, Werle L, Thierjung N, Lentzari I, Ortner M, Grimmer T, Laskaris N, Politis A, Gourzis P, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

J Neural Transm (Vienna). 2018 Feb;125(2):193-201. doi: 10.1007/s00702-017-1810-z. Epub 2017 Nov 15.

PMID:
29143217
9.

Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model.

Alexopoulos P, Panoutsopoulou K, Vogiatzis G, Koletsis E, Dougenis D, Tsopanoglou NE.

J Cardiovasc Pharmacol. 2017 Jul;70(1):34-41. doi: 10.1097/FJC.0000000000000492.

PMID:
28679129
10.

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.

Janel N, Alexopoulos P, Badel A, Lamari F, Camproux AC, Lagarde J, Simon S, Feraudet-Tarisse C, Lamourette P, Arbones M, Paul JL, Dubois B, Potier MC, Sarazin M, Delabar JM.

Transl Psychiatry. 2017 Jun 20;7(6):e1154. doi: 10.1038/tp.2017.123.

11.

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.

Alexopoulos P, Gleixner LS, Werle L, Buhl F, Thierjung N, Giourou E, Kagerbauer SM, Gourzis P, Kübler H, Grimmer T, Yakushev I, Martin J, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug;268(5):519-524. doi: 10.1007/s00406-017-0815-9. Epub 2017 Jun 10.

PMID:
28602012
12.

Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.

De Roeck A, Van den Bossche T, van der Zee J, Verheijen J, De Coster W, Van Dongen J, Dillen L, Baradaran-Heravi Y, Heeman B, Sanchez-Valle R, Lladó A, Nacmias B, Sorbi S, Gelpi E, Grau-Rivera O, Gómez-Tortosa E, Pastor P, Ortega-Cubero S, Pastor MA, Graff C, Thonberg H, Benussi L, Ghidoni R, Binetti G, de Mendonça A, Martins M, Borroni B, Padovani A, Almeida MR, Santana I, Diehl-Schmid J, Alexopoulos P, Clarimon J, Lleó A, Fortea J, Tsolaki M, Koutroumani M, Matěj R, Rohan Z, De Deyn P, Engelborghs S, Cras P, Van Broeckhoven C, Sleegers K; European Early-Onset Dementia (EU EOD) consortium.

Acta Neuropathol. 2017 Sep;134(3):475-487. doi: 10.1007/s00401-017-1714-x. Epub 2017 Apr 27.

13.

Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.

Robb C, Udeh-Momoh C, Wagenpfeil S, Schöpe J, Alexopoulos P, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;58(1):69-78. doi: 10.3233/JAD-161162.

14.

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, Bäumer V, Engelborghs S, De Bleecker J, Baets J, Gelpi E, Rojas-García R, Clarimón J, Lleó A, Diehl-Schmid J, Alexopoulos P, Perneczky R, Synofzik M, Just J, Schöls L, Graff C, Thonberg H, Borroni B, Padovani A, Jordanova A, Sarafov S, Tournev I, de Mendonça A, Miltenberger-Miltényi G, Simões do Couto F, Ramirez A, Jessen F, Heneka MT, Gómez-Tortosa E, Danek A, Cras P, Vandenberghe R, De Jonghe P, De Deyn PP, Sleegers K, Cruts M, Van Broeckhoven C, Goeman J, Nuytten D, Smets K, Robberecht W, Damme PV, Bleecker J, Santens P, Dermaut B, Versijpt J, Michotte A, Ivanoiu A, Deryck O, Bergmans B, Delbeck J, Bruyland M, Willems C, Salmon E, Pastor P, Ortega-Cubero S, Benussi L, Ghidoni R, Binetti G, Hernández I, Boada M, Ruiz A, Sorbi S, Nacmias B, Bagnoli S, Sorbi S, Sanchez-Valle R, Llado A, Santana I, Rosário Almeida M, Frisoni GB, Maetzler W, Matej R, Fraidakis MJ, Kovacs GG, Fabrizi GM, Testi S.

Hum Mutat. 2017 Mar;38(3):297-309. doi: 10.1002/humu.23161. Epub 2017 Jan 19.

15.

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease.

Alexopoulos P, Werle L, Roesler J, Thierjung N, Gleixner LS, Yakushev I, Laskaris N, Wagenpfeil S, Gourzis P, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2016 Dec 9;8(1):51.

16.

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer's Disease.

Ortner M, Pasquini L, Barat M, Alexopoulos P, Grimmer T, Förster S, Diehl-Schmid J, Kurz A, Förstl H, Zimmer C, Wohlschläger A, Sorg C, Peters H.

Front Neurol. 2016 Sep 19;7:132. eCollection 2016.

17.

Additive sex-specific influence of common non-synonymous DISC1 variants on amygdala, basal ganglia, and white cortical surface area in healthy young adults.

Mühle C, Kreczi J, Rhein C, Richter-Schmidinger T, Alexopoulos P, Doerfler A, Lenz B, Kornhuber J.

Brain Struct Funct. 2017 Mar;222(2):881-894. doi: 10.1007/s00429-016-1253-6. Epub 2016 Jul 1.

PMID:
27369464
18.

Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's Disease.

Trebeschi S, Riederer I, Preibisch C, Bohn KP, Förster S, Alexopoulos P, Zimmer C, Kirschke JS, Valentinitsch A.

Front Neurosci. 2016 Apr 19;10:154. doi: 10.3389/fnins.2016.00154. eCollection 2016.

19.

Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sex.

Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, Förstl H, Bickel H, Diehl-Schmid J.

Neuropsychiatr Dis Treat. 2015 Dec 17;11:3105-10. doi: 10.2147/NDT.S95018. eCollection 2015.

20.

The New Conceptualization of Alzheimer's Disease under the Microscope of Influential Definitions of Disease.

Alexopoulos P, Kurz A.

Psychopathology. 2015;48(6):359-67. doi: 10.1159/000441327. Epub 2015 Nov 27. Review.

PMID:
26610315
21.

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.

Grimmer T, Wutz C, Alexopoulos P, Drzezga A, Förster S, Förstl H, Goldhardt O, Ortner M, Sorg C, Kurz A.

J Nucl Med. 2016 Feb;57(2):204-7. doi: 10.2967/jnumed.115.163717. Epub 2015 Nov 19.

22.

Trends of patient referral to a memory clinic and towards earlier diagnosis from 1985-2009.

Grimmer T, Beringer S, Kehl V, Alexopoulos P, Busche A, Förstl H, Goldhardt O, Natale B, Ortner M, Peters H, Riedl L, Roßmeier C, Valentin W, Diehl-Schmid J, Kurz A.

Int Psychogeriatr. 2015 Dec;27(12):1939-44. doi: 10.1017/S104161021500157X. Epub 2015 Oct 2.

PMID:
26424328
23.

Altered serum fatty acid composition in geriatric depression.

Marx I, Alexopoulos P, Irmisch G, Topalidis S, Syrgiannis Z, Herpertz SC, Cohrs S.

J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):119-126. doi: 10.1007/s00702-015-1466-5. Epub 2015 Sep 29.

PMID:
26419596
24.

Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.

Cacace R, Van den Bossche T, Engelborghs S, Geerts N, Laureys A, Dillen L, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Tsolaki M, Koutroumani M, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matej R, Rohan Z, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cras P, van der Zee J, Sleegers K, Van Broeckhoven C; Belgium Neurology (BELNEU) Consortium and the European Early-Onset Dementia (EU EOD) Consortium.

Hum Mutat. 2015 Dec;36(12):1226-35. doi: 10.1002/humu.22908. Epub 2015 Oct 14.

25.

Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.

Alexopoulos P, Roesler J, Thierjung N, Werle L, Buck D, Yakushev I, Gleixner L, Kagerbauer S, Ortner M, Grimmer T, Kübler H, Martin J, Laskaris N, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2016 Oct;266(7):587-97. doi: 10.1007/s00406-015-0628-7. Epub 2015 Aug 8.

PMID:
26253588
26.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CAF, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Dec;11(12):1407-1416. doi: 10.1016/j.jalz.2014.12.009. Epub 2015 Apr 30.

27.

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study.

Cuyvers E, van der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, Dillen L, Merlin C, Geerts N, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, Diehl-Schmid J, Alexopoulos P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Sanchez-Valle R, Lladó A, Gelpi E, Almeida MR, Santana I, Clarimon J, Lleó A, Fortea J, de Mendonça A, Martins M, Borroni B, Padovani A, Matěj R, Rohan Z, Ruiz A, Frisoni GB, Fabrizi GM, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K; BELNEU Consortium and of the EU EOD Consortium.

Neurobiol Aging. 2015 May;36(5):2005.e15-22. doi: 10.1016/j.neurobiolaging.2015.02.014. Epub 2015 Feb 19.

28.

Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.

Stamatelopoulos K, Sibbing D, Rallidis LS, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis CC, Kastritis E, Alevizaki M, Tselepis AD, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher AM, Stellos K.

J Am Coll Cardiol. 2015 Mar 10;65(9):904-16. doi: 10.1016/j.jacc.2014.12.035.

29.

Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's disease.

Schulte EC, Kurz A, Alexopoulos P, Hampel H, Peters A, Gieger C, Rujescu D, Diehl-Schmid J, Winkelmann J.

Hum Genome Var. 2015 Jan 9;2:14028. doi: 10.1038/hgv.2014.28. eCollection 2015.

30.

The common acid sphingomyelinase polymorphism p.G508R is associated with self-reported allergy.

Reichel M, Richter-Schmidinger T, Mühle C, Rhein C, Alexopoulos P, Schwab SG, Gulbins E, Kornhuber J.

Cell Physiol Biochem. 2014;34(1):82-91. doi: 10.1159/000362986. Epub 2014 Jun 16.

31.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1.

32.

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.

van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, Matěj R, Vandenbulcke M, Sieben A, Dermaut B, Smets K, Van Damme P, Merlin C, Laureys A, Van Den Broeck M, Mattheijssens M, Peeters K, Benussi L, Binetti G, Ghidoni R, Borroni B, Padovani A, Archetti S, Pastor P, Razquin C, Ortega-Cubero S, Hernández I, Boada M, Ruiz A, de Mendonça A, Miltenberger-Miltényi G, do Couto FS, Sorbi S, Nacmias B, Bagnoli S, Graff C, Chiang HH, Thonberg H, Perneczky R, Diehl-Schmid J, Alexopoulos P, Frisoni GB, Bonvicini C, Synofzik M, Maetzler W, vom Hagen JM, Schöls L, Haack TB, Strom TM, Prokisch H, Dols-Icardo O, Clarimón J, Lleó A, Santana I, Almeida MR, Santiago B, Heneka MT, Jessen F, Ramirez A, Sanchez-Valle R, Llado A, Gelpi E, Sarafov S, Tournev I, Jordanova A, Parobkova E, Fabrizi GM, Testi S, Salmon E, Ströbel T, Santens P, Robberecht W, De Jonghe P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C.

Acta Neuropathol. 2014 Sep;128(3):397-410. doi: 10.1007/s00401-014-1298-7. Epub 2014 Jun 5.

33.

Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease.

Alexopoulos P, Kriett L, Haller B, Klupp E, Gray K, Grimmer T, Laskaris N, Förster S, Perneczky R, Kurz A, Drzezga A, Fellgiebel A, Yakushev I; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Nov;10(6):684-9. doi: 10.1016/j.jalz.2014.03.006. Epub 2014 May 22.

PMID:
24857233
34.

Right upper lobe partial anomalous pulmonary venous connection.

Tourmousoglou C, Kalogeropoulou C, Koletsis E, Charoulis N, Prokakis C, Alexopoulos P, Margaritis E, Dougenis D.

Case Rep Vasc Med. 2014;2014:249896. doi: 10.1155/2014/249896. Epub 2014 Feb 16.

35.

Neuroanatomical correlates of intelligence in healthy young adults: the role of basal ganglia volume.

Rhein C, Mühle C, Richter-Schmidinger T, Alexopoulos P, Doerfler A, Kornhuber J.

PLoS One. 2014 Apr 3;9(4):e93623. doi: 10.1371/journal.pone.0093623. eCollection 2014.

36.

Pancoast tumors: characteristics and preoperative assessment.

Panagopoulos N, Leivaditis V, Koletsis E, Prokakis C, Alexopoulos P, Baltayiannis N, Hatzimichalis A, Tsakiridis K, Zarogoulidis P, Zarogoulidis K, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Tsiouda T, Kesisis G, Siminelakis S, Madesis A, Dougenis D.

J Thorac Dis. 2014 Mar;6 Suppl 1:S108-15. doi: 10.3978/j.issn.2072-1439.2013.12.29. Review.

37.

Small vessel disease, but neither amyloid load nor metabolic deficit, is dependent on age at onset in Alzheimer's disease.

Ortner M, Kurz A, Alexopoulos P, Auer F, Diehl-Schmid J, Drzezga A, Förster S, Förstl H, Perneczky R, Sorg C, Yousefi BH, Grimmer T.

Biol Psychiatry. 2015 Apr 15;77(8):704-10. doi: 10.1016/j.biopsych.2014.01.019. Epub 2014 Jan 31.

PMID:
24613195
38.

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's Disease in humans in-vivo.

Grimmer T, Goldhardt O, Guo LH, Yousefi BH, Förster S, Drzezga A, Sorg C, Alexopoulos P, Förstl H, Kurz A, Perneczky R.

Neuroimage Clin. 2014 Feb 5;4:411-6. doi: 10.1016/j.nicl.2014.01.016. eCollection 2014.

39.

Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers.

Perneczky R, Alexopoulos P, Kurz A.

Trends Mol Med. 2014 Jan;20(1):8-15. Review.

PMID:
24524150
40.

Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease.

Perneczky R, Alexopoulos P; Alzheimer's Disease euroimaging Initiative.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S425-S429.e1. doi: 10.1016/j.jalz.2013.09.006. Epub 2013 Nov 13.

41.

Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.

Alexopoulos P, Guo LH, Jiang M, Bujo H, Grimmer T, Förster S, Drzezga A, Kurz A, Perneczky R.

J Alzheimers Dis. 2013;36(2):401-8. doi: 10.3233/JAD-122329.

PMID:
23609762
42.

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer's disease.

Guo LH, Alexopoulos P, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2013 Oct;263(7):553-60. doi: 10.1007/s00406-013-0405-4. Epub 2013 Apr 17.

PMID:
23591828
43.

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease.

Perneczky R, Guo LH, Kagerbauer SM, Werle L, Kurz A, Martin J, Alexopoulos P.

Transl Psychiatry. 2013 Feb 19;3:e227. doi: 10.1038/tp.2013.11.

44.

Plasma proteomics for the identification of Alzheimer disease.

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

45.

Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study.

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 Sep;9(5):580-6. doi: 10.1016/j.jalz.2012.10.002. Epub 2012 Dec 8.

PMID:
23232272
46.

β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau.

Tsolakidou A, Alexopoulos P, Guo LH, Grimmer T, Westerteicher C, Kratzer M, Jiang M, Bujo H, Roselli F, Leante MR, Livrea P, Kurz A, Perneczky R.

Alzheimers Dement. 2013 Jul;9(4):386-91. doi: 10.1016/j.jalz.2012.01.015. Epub 2012 Nov 3.

PMID:
23127467
47.

The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.

Guo LH, Alexopoulos P, Eisele T, Wagenpfeil S, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):325-33. doi: 10.1007/s00406-012-0349-0. Epub 2012 Aug 30.

PMID:
22932720
48.

Feeding Tube-related Complications and Problems in Patients Receiving Long-term Home Enteral Nutrition.

Alivizatos V, Gavala V, Alexopoulos P, Apostolopoulos A, Bajrucevic S.

Indian J Palliat Care. 2012 Jan;18(1):31-3. doi: 10.4103/0973-1075.97346.

49.

White matter hyperintensities predict amyloid increase in Alzheimer's disease.

Grimmer T, Faust M, Auer F, Alexopoulos P, Förstl H, Henriksen G, Perneczky R, Sorg C, Yousefi BH, Drzezga A, Kurz A.

Neurobiol Aging. 2012 Dec;33(12):2766-73. doi: 10.1016/j.neurobiolaging.2012.01.016. Epub 2012 Mar 10.

PMID:
22410648
50.

SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease.

Guo LH, Westerteicher C, Wang XH, Kratzer M, Tsolakidou A, Jiang M, Grimmer T, Laws SM, Alexopoulos P, Bujo H, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2012 Sep;262(6):529-34.

PMID:
22286501

Supplemental Content

Loading ...
Support Center